{"filings":[{"id":860796,"accession_number":"0001437749-26-019558","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-06-04T20:02:48+00:00","items":["1.02","7.01"],"status":"ready","headline":"Accuray fully repays $18M 3.75% Convertible Senior Notes upon maturity","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Remaining $18M principal plus $337,500 interest repaid on June 1, 2026.","Notes matured June 1, 2026; indenture satisfied and discharged.","Company released from obligations under indenture except surviving provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91523,"accession_number":"0001437749-26-015198","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q3 revenue down 7% to $104.8M; net loss $11.8M; withdraws FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $11.8M ($0.09 per share) vs $1.3M loss YoY; Adjusted EBITDA $3.8M vs $6.0M.","Product revenue fell 13% to $49.7M; service revenue down 1% to $55.1M.","Gross margin 24.1% vs 27.9% YoY; operating expenses include $6.5M restructuring charges.","Order backlog $356.2M, down 21% YoY; gross product orders $48.5M vs $71.2M.","Withdrew FY2026 guidance due to Middle East geopolitical uncertainty impacting shipments; transformation plan delivered $10M in cost savings ahead of $12M target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":301028000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91522,"accession_number":"0001437749-26-013543","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray COO Leonel Peralta departs effective April 26, 2026; no disagreement cited","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonel Peralta, SVP and Chief Operations Officer, resigned effective April 26, 2026.","Departure not due to any disagreement with Accuray or its board on operations, policies, or practices.","No successor has been named in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91521,"accession_number":"0001437749-26-011547","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Accuray amends Dedication Capital consulting pact; cuts fees 50%, vests 916K shares immediately","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash compensation reduced 50%: Base fee $175K for Apr–Oct 2026, FY2026 incentive min $132.8K, Sep Q min $54.7K.","916,336 shares of Initial Restricted Shares (354,609 under 2016 plan, 561,727 under 2026) vested immediately as of Apr 1, 2026.","333,004 remaining Initial Restricted Shares to vest on Oct 31, 2026; PSAs still subject to stock price target.","Company expects at least $362,500 in cash savings from the amendment.","Consulting Agreement end date extended to October 31, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91520,"accession_number":"0001437749-26-011313","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray appoints Paul Miele as SVP and Chief Commercial Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paul Miele appointed Chief Commercial Officer effective April 6, 2026.","Miele joins from Johnson & Johnson MedTech where he led the MONARCH robotic platform.","He will lead global commercialization strategy including sales, marketing, and pricing.","CEO Steve La Neve cites Miele's track record in driving transformation and sales growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101664,"accession_number":"0001437749-26-009046","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-03-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray CCO Sandeep Chalke to depart March 31; separation includes $459K lump sum, equity vesting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sandeep Chalke, SVP & Chief Commercial Officer, leaves Accuray effective March 31, 2026.","Separation agreement provides $459,000 lump sum (12 months base salary) and prorated FY2026 bonus.","78,125 RSU shares originally vesting May 31, 2026 accelerate; all later equity forfeited.","Chalke executed a general release of claims and agreed to 12-month cooperation and non-disparagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101663,"accession_number":"0001437749-26-004223","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray posts Q2 FY2026 earnings presentation; no detailed figures in filing","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Posted investor presentation for fiscal 2026 second quarter earnings call on Feb 17, 2026.","Presentation available on Accuray's IR website; no financial data provided in the 8-K or exhibit.","Ticker: ARAY; presentation includes forward-looking statements and summary information."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":196183000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101662,"accession_number":"0001437749-26-003515","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-02-09T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"Accuray non-reliance on FY2025 and Q1 FY2026 financials over RPO footnote errors; no P&L impact","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee concluded audited FY2025 10-K and interim 10-Qs for FY2025 and Q1 FY2026 should no longer be relied upon due to RPO disclosure errors.","Errors isolated to the RPO footnote; no impact on balance sheets, income statements, or cash flows.","Material weaknesses identified in internal controls over financial reporting and disclosure controls; remediation plan underway.","Amended filings (10-K/A, 10-Q/A) to be filed; Q2 report expected within Rule 12b-25 extension period.","Errors caused by incorrect inclusion of open system/upgrade sales orders as RPO; methodology is being reassessed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101661,"accession_number":"0001437749-26-003367","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Accuray receives Nasdaq deficiency notice for bid price below $1; 180-day cure period","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received Nasdaq notice on Feb 2, 2026 for non-compliance with $1 minimum bid price rule.","Has 180-day compliance period until Aug 3, 2026 to regain compliance by closing bid >= $1 for 10 consecutive days.","May be eligible for second 180-day period by transferring to Nasdaq Capital Market if not cured initially.","Common stock continues trading under symbol ARAY while company evaluates options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101660,"accession_number":"0001437749-26-002976","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q2 net loss $0.11 per share; revenue down 12%; launches $25M transformation plan","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total net revenue $102.2M, down 12% YoY; product revenue fell 26% to $45.0M, service revenue up 4% to $57.2M.","Net loss $13.8M ($0.11 diluted EPS) vs prior-year net income $2.5M ($0.02 EPS); adjusted EBITDA negative $1.9M.","CEO Steve La Neve announced transformational plan targeting ~$25M annualized operating profit improvement, including ~15% global workforce reduction.","Q2 restructuring charges $6.1M; ~$13M total restructuring charges expected for FY2026.","Updated FY2026 guidance: revenue $440-450M, adjusted EBITDA $22-25M; backlog $383.3M down 17% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":196183000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101659,"accession_number":"0001193125-26-016769","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray CCO Sandeep Chalke resigns effective March 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sandeep Chalke, SVP & Chief Commercial Officer, will resign effective March 31, 2026.","Resignation is voluntary and not due to any disagreement with Accuray or its Board.","No successor has been named; Chalke will serve through the effective date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117995,"accession_number":"0001437749-25-039074","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray director Byron Scott to retire from board effective Dec 31, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Byron C. Scott, Class II director, informed board of retirement effective Dec 31, 2025.","Departure not due to any disagreement with company or its operations, policies, or practices.","Scott will resign from all board committees as of his retirement date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117994,"accession_number":"0001193125-25-319896","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["1.01","2.05","3.02","7.01","9.01"],"status":"ready","headline":"Accuray announces transformation plan; cuts 15% workforce, expects $25M annualized profit improvement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Workforce reduction of ~15% global headcount; total restructuring charges estimated at ~$11M, mostly cash.","Expects annualized operating profit improvement of ~$25M; ~$12M to be realized in FY2026.","Amends loan agreement: removes leverage condition for DDTL, reduces DDTL to $18.25M, delays covenant testing to Q4 FY2026.","Issues warrants for up to ~7M shares to lenders: exercise prices $1.50, $1.25, $0.01; additional warrants tied to DDTL draw.","Also pays $1.9M additional premiums and reduces revolver availability by $5M through Dec 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117993,"accession_number":"0001193125-25-288077","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-11-19T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Accuray shareholders approve 2026 equity plan, elect directors, ratify auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approval of 2026 Equity Incentive Plan authorizes up to 3,896,000 new shares plus rollover from prior plan.","All three Class I director nominees (Le Grand, Whitters, Galbato) elected with substantial support.","Advisory vote on executive compensation passed with ~87% of votes cast in favor.","Grant Thornton LLP ratified as independent auditor for FY2026 with 86.6M shares in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117992,"accession_number":"0001193125-25-266940","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q1 revenue down 7%, net loss widens to $21.7M; CEO replaced, restructuring initiated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $93.9M (-7% YoY); product revenue $37.2M (-23%); service revenue $56.8M (+7%).","Net loss $21.7M ($0.18/sh) vs loss $4.0M ($0.04) prior year; Adj. EBITDA loss $4.1M.","Appointed Steve La Neve as CEO, succeeding Suzanne Winter retiring; Steven F. Mayer as Transformation Board Sponsor.","Restructuring charges of $2.8M ($1.5M severance, $1.3M consulting) recorded in Q1.","FY2026 guidance reaffirmed: revenue $471M-$485M, Adj. EBITDA $31M-$35M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":93942000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117991,"accession_number":"0001193125-25-243143","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["1.01","2.02","5.02","9.01"],"status":"ready","headline":"Accuray appoints Steve La Neve as CEO; prelim Q1 rev $92.5-94M, adj EBITDA ~($4M)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve La Neve appointed President & CEO effective Oct 20, 2025; succeeds Suzanne Winter who retired.","Steven F. Mayer named Transformation Board Sponsor under one-year consulting agreement with $600K base fee plus equity.","Preliminary Q1 FY2026 revenue $92.5-94M (product rev below expectations in EIMEA and China).","Preliminary Q1 adjusted EBITDA approximately ($4M) due to geographic mix and joint-venture accounting.","Transformation plan targets high single-digit adjusted EBITDA margin run-rate within 12 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134452,"accession_number":"0001193125-25-209044","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-09-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray SVP, Chief Legal Officer Jesse Chew departs; consulting agreement through Dec 2025 at $20K/month","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jesse Chew ceased employment as SVP, Chief Legal Officer and Corporate Secretary on Sept 19, 2025.","Consulting agreement runs Sept 19 to Dec 31, 2025; retainer $20,000/month plus continued equity vesting.","Services include transition support for CEO/CHRO/VP AGC, stockholder meeting prep, and contracts system implementation.","Consulting does not include legal advice; Chew must avoid competitors and get CEO approval for other radiation oncology work."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134451,"accession_number":"0001193125-25-186407","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-08-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray director Kill not standing for re-election; Chief Legal Officer Chew to resign Sept 19","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert C. Kill, Class I director, will not stand for re-election at November 2025 annual meeting; continues until then.","Jesse Chew steps down as SVP, Chief Legal Officer and Corporate Secretary effective Sept 19, 2025.","Chew will consult through Dec 31, 2025 under terms to be agreed upon.","Both departures stated as not due to any disagreement with the company or board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134450,"accession_number":"0001193125-25-179806","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q4 revenue $127.5M (-5% YoY); full year net loss narrows to $1.6M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 revenue $127.5M, down 5% YoY; product revenue $70.7M (-11%), service revenue $56.8M (+4%).","Q4 net income $1.1M ($0.01 EPS) vs $3.4M ($0.03 EPS) prior year; adjusted EBITDA $9.4M vs $10.1M.","FY2025 revenue $458.5M (+3% YoY); net loss $1.6M vs $15.5M; adjusted EBITDA $28.3M vs $19.7M.","Backlog $427M, down 12.4% from FY2024 end; cash $58M, down $20.8M from Q3; debt refinancing completed.","FY2026 guidance mentioned but specific numbers not provided in the filing snippet."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":458505000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151292,"accession_number":"0000950103-25-007090","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["1.01","1.02","2.03","3.02","5.02","8.01","9.01"],"status":"ready","headline":"Accuray refinances debt: $150M term loan from TCW, exchanges $82M notes for stock & cash","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Exchanged ~$82M of 3.75% convertible notes for 8.88M shares and ~$68.6M cash; $18M of notes remain outstanding.","New $150M term loan, $20M delayed draw, $20M revolver with TCW; matures June 2030; interest SOFR+8.5% or base+7.5%.","Issued 17.2M Premium Warrants ($1.68 strike, 6-month lockout) and 6.25M Penny Warrants ($0.01 strike) to lenders.","Appointed Steven F. Mayer (TCW designee) to board; TCW also gets two non-voting observer seats.","Proceeds used to fully repay existing SVB credit facility and fund note exchange; existing agreement terminated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151291,"accession_number":"0000950170-25-061055","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q3 revenue $113.2M (+12% YoY); FY revenue guidance cut to $452-460M on tariffs","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net loss narrowed to $1.3M ($0.01/sh) from $6.3M ($0.06/sh) a year ago; adjusted EBITDA rose to $6.0M from $1.1M.","Product revenue $57.3M (+16%), service revenue $55.9M (+9%); gross margin 27.9% vs 28.7%.","Gross product orders fell to $71.2M from $89.1M; backlog $452.4M, down ~10% YoY.","FY 2025 total revenue guidance lowered to $452-460M due to tariff impact on product volume; adjusted EBITDA reaffirmed at $28.5-31.0M.","CEO cites disciplined execution and underlying demand despite tariff headwinds."],"consensus_eps_estimate":-0.0612,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":330962000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170178,"accession_number":"0000950170-25-016249","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-02-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray appoints Leonel Peralta COO with $450K base, $80K sign-on, $750K RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonel Peralta named SVP, Chief Operations Officer effective Feb 3, 2025; previously VP Global Operations at Siemens Healthineers.","Base salary $450K, sign-on $80K, annual bonus target 60% of base, performance bonus up to $300K.","RSU grant of $750K vesting 25% annually over four years.","Severance: 12 months salary without cause; 24 months salary + 200% target bonus on change-in-control termination.","Full equity acceleration on change-in-control termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170177,"accession_number":"0000950170-25-014445","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-02-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q2 FY2025 revenue up 8% to $116.2M, net income $2.5M; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $116.2M (+8% YoY); net income $2.5M ($0.03 EPS) vs loss $9.6M ($0.10 loss) prior year.","Adjusted EBITDA $9.6M vs $2.0M prior year; product revenue up 19% to $61.2M.","Gross product orders $76.8M (down 18% YoY); backlog $463.1M (down 6% YoY).","FY2025 guidance raised: revenue $463M-$475M; adjusted EBITDA $28.5M-$31.0M.","Cash $64.0M, up $4.3M from Sep 30; operating expenses down 7% to $37.2M."],"consensus_eps_estimate":0.0179,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":217719000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170176,"accession_number":"0000950170-25-007015","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2025-01-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray hires Leonel Peralta as SVP, Chief Operations Officer effective Feb 3, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Peralta will lead worldwide manufacturing operations and supply chain, reporting to CEO Suzanne Winter.","He brings 25+ years of leadership experience, most recently VP of Global Operations at Siemens Healthineers ultrasound.","Previous executive roles at Medtronic Diabetes, Hill-Rom (Baxter), KCI Medical (3M), and GE Healthcare.","CEO cites expanded portfolio and need for operational efficiencies as catalyst for the hire."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187186,"accession_number":"0001193125-24-275526","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray SVP Global Operations Michael Hoge departing Jan 6, 2025; successor search initiated","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Hoge, SVP Global Operations, will leave Accuray effective January 6, 2025, by mutual agreement with no dispute.","Company has begun a comprehensive search for Hoge's successor.","Hoge qualifies for severance: 12 months base salary lump sum, prorated FY2025 bonus, and 12 months COBRA premium reimbursement (subject to release).","The departure is not the result of any disagreement with management or board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187185,"accession_number":"0000950170-24-130548","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Accuray shareholders approve equity plan increases; appoints new principal accounting officer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to 2016 Equity Incentive Plan, adding 5,000,000 shares to reserve.","Stockholders approved amendment to 2007 Employee Stock Purchase Plan, adding 2,500,000 shares.","Michael Murphy appointed Principal Accounting Officer, effective December 2, 2024.","James Hindman and Suzanne Winter elected as Class III directors through 2027.","Grant Thornton LLP ratified as independent auditor for fiscal year ending June 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187184,"accession_number":"0000950170-24-122304","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray reports Q1 FY2025 revenue $101.5M, net loss $4.0M; raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $101.5M (down 2% YoY); service revenue grew to $53.2M (+5% YoY) offsetting product decline.","Net loss $4.0M ($0.04 diluted loss per share); Adjusted EBITDA $3.1M vs $6.5M in prior year Q1.","Gross product orders $55.4M (down 13% YoY); backlog $468.6M (down ~4% YoY).","Cash $59.7M, down $9.4M from June 30 due to inventory buildup for increased shipments.","Company raises fiscal 2025 guidance citing strong China region, Tomo C system, and service growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":101545000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187183,"accession_number":"0000950170-24-115941","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-10-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray appoints Michael Murphy as VP, Corporate Controller, effective Oct 21","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Murphy, CPA, appointed VP, Corporate Controller, leading global accounting, tax, regulatory reporting, and risk management.","He reports to CFO Ali Pervaiz; expected to become principal accounting officer after Q1 FY2025 10-Q filing.","Murphy previously served as VP, CAO & Treasury at Duluth Holdings and had roles at KPMG, First Business Financial, and Banco Popular.","He brings over 15 years of finance and accounting experience, with a track record of cost savings and cross-functional leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187182,"accession_number":"0000950170-24-114477","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Accuray CEO Suzanne Winter returns from medical leave; Chalke resumes CCO role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Suzanne Winter resumed duties as President and CEO effective October 15, 2024.","Sandeep Chalke served as interim CEO during Winter's leave; now returns to SVP, CCO.","Board chair Joseph Whitters expressed delight at Winter's return and thanked Chalke.","No additional operational or financial changes announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203694,"accession_number":"0000950170-24-106804","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-09-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Accuray amends credit pact; revolver cut to $20M, added liquidity covenant","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Available revolving commitments reduced to no more than $20 million under Fourth Amendment.","Added Minimum Liquidity covenant to the credit agreement.","Consolidated Fixed Charge Coverage Ratio and Senior Net Leverage Ratio modified for Q1 FY2025.","Silicon Valley Bank remains administrative agent; amendment effective September 12, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203693,"accession_number":"0001193125-24-212084","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Accuray CEO Suzanne Winter takes temporary medical leave; Sandeep Chalke named interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Suzanne Winter taking temporary medical leave to treat a treatable form of cancer, effective September 3, 2024.","Sandeep Chalke, Chief Commercial Officer, appointed interim CEO; compensation raised to $725k base salary and 100% bonus target.","Board forms Executive Committee (Joseph Whitters and Anne Le Grand) to advise interim CEO during leave.","Winter: 'I go into my treatment program extremely knowledgeable and able to advocate for the care I need.'"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203692,"accession_number":"0000950170-24-096978","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q4 revenue up 13.5% to $134.3M; posts net income of $3.4M; FY25 guidance issued","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 revenue $134.3M (+13.5% YoY); GAAP net income $3.4M vs loss $2.6M; Adj EBITDA $10.1M vs $5.2M.","FY24 revenue $446.6M (-0.2%); net loss $15.5M vs $9.3M; Adj EBITDA $19.7M vs $23.9M.","Gross orders Q4 $95.5M (+7.9%), FY $342.1M (+10%); backlog $487.3M.","Record quarterly system shipments up 24%; VitalHold SGRT installed in Japan; CE Mark for Helix; China TPS approval.","Cash $69.1M, +$7.9M QoQ; FY25 guidance issued (specifics not provided in filing excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":446551000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220237,"accession_number":"0000950170-24-057777","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray CFO Ali Pervaiz named interim principal accounting officer after CAO resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gina Corradetti resigns as VP, Chief Accounting Officer, effective May 17, 2024.","Ali Pervaiz (SVP & CFO) appointed interim principal accounting officer effective May 17, 2024 until a permanent successor is appointed.","Mr. Pervaiz will receive no additional compensation for the interim role.","Mr. Pervaiz has been CFO since May 2022; prior 15+ years at GE Healthcare."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220236,"accession_number":"0000950170-24-051248","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["1.01","2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q3 revenue down 14% to $101.1M; net loss $6.3M vs prior income $0.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $101.1M (-14% YoY); product $49.6M, service $51.5M.","GAAP net loss $6.3M ($0.06/share) vs prior-year net income $0.6M ($0.01/share).","Adjusted EBITDA $1.1M vs $8.3M; gross margin 28.7% vs 32.8% YoY.","Gross orders $89.1M (+21% YoY); book-to-bill 1.8; backlog $503.2M.","Credit agreement amendment allows up to $2.6M restructuring and $6.8M cost savings add-back to EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":312262000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239919,"accession_number":"0000950170-24-009384","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2024-01-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q2 revenue falls 7% to $107.2M, net loss widens; orders up 19%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss $9.6M ($0.10/sh) vs $1.9M loss a year ago; adjusted EBITDA $2.0M down from $8.5M.","Gross orders $93.9M (+19% YoY), book-to-bill 1.8; backlog $492.1M.","Service revenue $55.7M (+8% YoY); product revenue $51.5M (-19% YoY).","Cash and equivalents $73.2M, down $16.7M from June 30, 2023.","FY24 revenue and adjusted EBITDA guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":211130000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257439,"accession_number":"0000950170-23-064162","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-11-15T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Stockholders approve amendment to 2016 Equity Incentive Plan, increasing authorized shares by 5 million","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["At Nov 9, 2023 annual meeting, stockholders approved amendment to 2016 Equity Incentive Plan, increasing authorized shares by 5,000,000.","Elected Beverly A. Huss, Mika Nishimura, and Byron C. Scott as Class II directors until 2026 annual meeting.","Advisory say-on-pay vote passed with ~52.9M votes in favor; company will hold annual votes going forward.","Ratified Grant Thornton LLP as independent auditor for FY2024 with 75.2M votes in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257438,"accession_number":"0000950170-23-060231","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q1 revenue $103.9M (+7.7% YoY), net loss narrows to $3M, reaffirms FY2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $103.9M (+7.7% YoY); product rev $53.4M (+19.7%), service rev $50.5M (-2.7%).","GAAP net loss $3.0M ($0.03 diluted loss) vs loss $5.4M ($0.06) prior year; adj EBITDA $6.5M vs $1.9M.","Gross orders $63.7M (book-to-bill 1.2); order backlog $489M, down 9.2% YoY.","Cash $77.4M, down $12.5M from Q4 FY2023; reiterated FY2024 financial guidance.","Operational highlights: FDA clearance and CE mark for VitalHold; China NMPA approval for Tomo C."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":103892000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257437,"accession_number":"0000950170-23-055350","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.05","9.01"],"status":"ready","headline":"Accuray cuts ~5.9% of workforce as part of margin expansion plan, expects $2.5M cost in Q2 FY2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Workforce reduction of ~5.9% committed Sept 13; employees informed Oct 25.","Estimated total cost ~$2.5 million, expected to be recorded in fiscal Q2 2024.","Initiative part of margin expansion plan; expected substantially complete in Q2 FY2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257436,"accession_number":"0000950170-23-051504","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray presents long-term growth strategy at ASTRO 2023; no financial updates disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company presented management slides at ASTRO 2023 investor briefing on Oct 3, 2023.","Slides discuss long-term business and growth strategies, but no specific financial data or guidance provided.","Presentation available on company's IR website; slides furnished as Exhibit 99.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274777,"accession_number":"0000950170-23-048984","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-09-20T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Accuray adopts amended bylaws with federal forum selection clause for Securities Act claims","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved amended bylaws effective September 14, 2023, aligning with Delaware law.","Enhanced procedural mechanics and disclosure for stockholder nominations and proposals.","Adopted exclusive federal forum for Securities Act claims; company may consent otherwise.","Clarified existing Delaware exclusive forum provision and made conforming updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274776,"accession_number":"0000950170-23-040538","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q4 revenue $118.3M (+7.5%); FY GAAP net loss $9.3M vs $5.3M prior year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $118.3M (+7.5% YoY); GAAP net loss $2.6M ($0.03/share) vs loss $3.5M prior year.","FY2023 net revenue $447.6M (+4.1%); GAAP net loss $9.3M ($0.10/share) vs loss $5.3M prior year.","Adjusted EBITDA Q4 $5.2M (includes $2M bad debt reserve from customer bankruptcy); FY23 $23.9M vs $22.8M prior year.","Gross orders Q4 $88.4M (1.4 book-to-bill); FY23 $311.1M (1.3 book-to-bill); backlog $510.6M.","Issued FY2024 guidance; highlights: 5% installed base growth, positive free cash flow, 510(k) clearance for VitalHold breast package."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":447605000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274775,"accession_number":"0000950170-23-038550","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-08-04T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Accuray relocates corporate headquarters to Madison, Wisconsin","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Effective July 31, 2023, headquarters moved to 1240 Deming Way, Madison, WI 53717-1954.","No financial or operational impact disclosed; move is purely administrative.","Previous headquarters address not specified in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292101,"accession_number":"0000950170-23-014789","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Accuray Q3 revenue $118.1M (+22.8% YoY), net income $0.6M, record 30 systems shipped","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record quarterly revenue $118.1M, up 22.8% YoY; constant currency revenue $122.1M (+27%).","GAAP net income $0.6M ($0.01 EPS) vs net loss $1.0M; adjusted EBITDA $8.3M, up 53.5% from $5.4M.","Shipped record 30 systems (+67% YoY); product revenue $62.8M (+45% YoY); 1,000+ installed base milestone.","Gross orders $73.8M (book-to-bill 1.2); backlog $506.6M (-12.7% YoY); $5.2M cancellations, $26.4M aged out.","Reiterated fiscal 2023 guidance; cash $89.2M, up $21.3M from Dec 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":329313000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312847,"accession_number":"0000950170-23-007852","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Elizabeth Dávila to retire from Accuray board effective April 30, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Elizabeth Dávila, a Class III director, will retire from the Board and all committees effective April 30, 2023.","Her departure is to pursue other interests and not due to any disagreement with the Company.","No replacement has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312846,"accession_number":"0000950170-23-007350","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-03-10T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Accuray says SVB exposure immaterial; cash under $250k FDIC limit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash at Silicon Valley Bank is below $250,000, fully within FDIC insurance coverage.","No securities or other assets are held at SVB; exposure is considered immaterial.","Disclosure responds to media reports of a possible liquidity concern at SVB."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312845,"accession_number":"0000950170-23-006133","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-03-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray presents at Cowen conference; no material new disclosures in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Accuray presented at Cowen 43rd Annual Health Care Conference on March 6, 2023.","Presentation slides discuss long-term business and growth strategies.","Slides posted on investor relations website; no specific financial guidance or material events disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312844,"accession_number":"0000950170-23-002709","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-02-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Accuray presents at BTIG conference; slides discuss long-term growth strategy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation slides furnished as Exhibit 99.1 cover innovation-driven growth strategy.","Slides used at BTIG MedTech conference and posted on investor relations website.","No specific financial guidance, results, or material changes disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312843,"accession_number":"0000950170-23-001596","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-02-01T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Accuray Q2 fiscal 2023 revenue $114.8M, net loss $1.9M; reiterates full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue of $114.8M, down 1.3% YoY; GAAP net loss $1.9M vs income $0.2M last year.","Adjusted EBITDA rose 24% to $8.5M; operating expenses down 2% excluding non-recurring charges.","Gross orders $79.0M, down 7.4% YoY but up 13.2% sequentially; backlog $515.2M, down 11.4% YoY.","Robert C. Kill appointed to Board of Directors effective Jan 30, 2023; initial RSU grant $150K."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":211253000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312842,"accession_number":"0000950170-23-000329","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2023-01-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray signs consulting agreement with departing CAO Palomba; new exec employment contracts","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Former CAO Franco Palomba departed Jan 3, 2023; consulting agreement at $375/hr through Mar 10, 2023.","New 3-year employment agreements for CEO Winter, CFO Pervaiz, GC Chew, and Global Ops VP Hoge effective Jan 1, 2023.","CEO salary $650k, target bonus 100%; CFO $427.5k/70%; GC $457.6k/60%; Ops $400.4k/60%.","Severance: non-CIC 12 months base; CIC 24 months base + 200% target bonus + full equity vesting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331353,"accession_number":"0000950170-22-026949","cik":1138723,"company_name":"ACCURAY INC","ticker":"ARAY","form_type":"8-K","filed_at":"2022-12-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Accuray CAO Franco Palomba resigns; Gina Corradetti appointed effective Jan 3, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chief Accounting Officer Franco Palomba resigns effective Jan 3, 2023, for personal reasons; no disagreement with company.","Gina Corradetti, 49, appointed as new CAO, also effective Jan 3. She joined as VP, Controller in Dec 2022.","Corradetti previously Corporate Controller at Gynesonics and Assistant Corporate Controller at Varian Medical Systems.","No additional compensation for appointment; standard indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":50071820.232378006,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-12-22T23:59:59+00:00|331353"}